Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Classificação em ações #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Preço da ação
$0.1
Última sincronização: 2024-06-18
Valor de mercado
$1.31M
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Pascal Biosciences Inc. (PSCBF)

Categoria

Lucros da Pascal Biosciences Inc. (PSCBF)
Lucros em Feb 2024 TTM: $-247.59K
De acordo com os últimos relatórios financeiros da Pascal Biosciences Inc., os ganhos atuais da empresa são de $-247.59K. Em 2022, a empresa teve ganhos de $-359.87K, um aumento em relação a aos ganhos de 2021, que foram de $-853.00K. Os ganhos apresentados nesta página são os ganhos antes de juros e impostos, conhecidos como EBIT.
Histórico de lucros da Pascal Biosciences Inc. de 2019 a 2026
Lucros no final de cada ano
Ano Lucros Alterar
2026 (TTM) $-247.59K -15.84%
2023 $-294.20K -18.25%
2022 $-359.87K -57.81%
2021 $-853.00K -9.78%
2020 $-945.48K -63.20%
2019 $-2.57M 0.00%
Lucros de empresas semelhantes ou concorrentes
Empresa Lucros Diferença de Lucros País
$5.27B -2,130,610.56%
US
$1.95B -787,959.61%
NL
- -
CH
- -
KR
$3.01B -1,214,096.90%
BE